Management tracks: Five Prime, CytoSen

Cancer play Five Prime Therapeutics Inc. (NASDAQ:FPRX) promoted Aron Knickerbocker to president and CEO from COO, effective Jan. 1, 2018. He succeeds Lewis Williams, who will

Read the full 267 word article

How to gain access

Continue reading with a
two-week free trial.